Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Yusuf, 2001, Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization, Circulation, 104, 2746, 10.1161/hc4601.099487 Yusuf, 1985, Beta blockade during and after myocardial infarction: an overview of the randomized trials, Prog Cardiovasc Dis, 27, 335, 10.1016/S0033-0620(85)80003-7 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301 Dagenais, 2006, Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials, Lancet, 368, 581, 10.1016/S0140-6736(06)69201-5 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5 1994, Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ, 308, 81, 10.1136/bmj.308.6921.81 Yusuf, 2002, Two decades of progress in preventing vascular disease, Lancet, 360, 2, 10.1016/S0140-6736(02)09358-3 Wald, 2003, A strategy to reduce cardiovascular disease by more than 80%, BMJ, 326, 1419, 10.1136/bmj.326.7404.1419 Sacco, 2006, Stroke, 37, 577, 10.1161/01.STR.0000199147.30016.74 Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II and III surveys in eight European countries, Lancet, 337, 929, 10.1016/S0140-6736(09)60330-5 Fox, 2007, Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006, JAMA, 297, 1892, 10.1001/jama.297.17.1892 Bhatt, 2010, Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherosthrombosis, JAMA, 304, 1350, 10.1001/jama.2010.1322 Teo, 2009, The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low, middle- and high-income countries, Am Heart J, 158, 1, 10.1016/j.ahj.2009.04.019 MacQueen, 2001, What is community? An evidence-based definition for participatory public health, Am J Public Health, 91, 1929, 10.2105/AJPH.91.12.1929 Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9 O'Donnell, 2010, Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study, Lancet, 376, 112, 10.1016/S0140-6736(10)60834-3 Ramsey, 2002 Joshi, 2009, Fatal and nonfatal cardiovascular disease and the use of therapies for secondary prevention in a rural region of India, Circulation, 119, 1950, 10.1161/CIRCULATIONAHA.108.819201 Mendis, 2005, WHO study on prevention of recurrences of myocardial infarction and stroke (WHO-PREMISE), Bull World Health Organ, 83, 820 Xavier, 2008, Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data, Lancet, 371, 1435, 10.1016/S0140-6736(08)60623-6 Cameron, 2011, Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries, Bull World Health Organ, 89, 412, 10.2471/BLT.10.084327 Van Mourik, 2010, Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data, BMC Cardiovasc Disord, 10, 25, 10.1186/1471-2261-10-25 Haynes, 2008, Interventions for enhancing medication adherence, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD000011.pub3 Niëns, 2010, Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world, PLoS Med, 7, e1000333, 10.1371/journal.pmed.1000333 Healy, 1991, The Yentl syndrome, N Engl J Med, 325, 274, 10.1056/NEJM199107253250408 John, 2008, Crowding out effect of tobacco expenditure and its implications on household resource allocation in India, Soc Sci Med, 66, 1356, 10.1016/j.socscimed.2007.11.020 Osterberg, 2005, Adherence to medication, N Engl J Med, 353, 487, 10.1056/NEJMra050100 Bergmann, 1998, Validity of self-reported diagnoses leading to hospitalization: a comparison of self-reports with hospital records in a prospective study of American adults, Am J Epidemiol, 147, 969, 10.1093/oxfordjournals.aje.a009387 Okura, 2004, Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure, J Clin Epidemiol, 57, 1096, 10.1016/j.jclinepi.2004.04.005 Yamagishi, 2009, Self-reported stroke and myocardial infarction had adequate sensitivity in a population-based prospective study JPHC (Japan Public Health Center)-based prospective study, J Clin Epidemiol, 62, 667, 10.1016/j.jclinepi.2008.07.016 Lampe, 1999, Validity of a self-reported history of doctor-diagnosed angina, J Clin Epidemiol, 52, 73, 10.1016/S0895-4356(98)00146-2 Heckbert, 2004, Comparison of self-report, hospital discharge codes and adjudication of cardiovascular events in the Women's Health Initiative, Am J Epidemiol, 160, 1152, 10.1093/aje/kwh314 2009, Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial, Lancet, 373, 1341, 10.1016/S0140-6736(09)60611-5 Lonn, 2010, The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions, Circulation, 122, 2078, 10.1161/CIRCULATIONAHA.109.873232